Byetta Matches Lantus for Type 2 Control

Similar improvements in overall blood glucose control

| Jan 1, 2006

Exenatide (Byetta) and insulin glargine (Lantus) achieve similar improvements in overall blood glucose control in people with type 2 diabetes who were not being controlled sufficiently on oral combination therapy.

In a 26-week multicenter randomized trial, physicians compared the effects of Byetta and Lantus on 551 patients with type 2 diabetes who had A1Cs ranging from 7% to 10% despite combination metformin and sulfonylurea therapy. Byetta was administered at dosages of 10 µg twice daily, or Lantus was administered once daily to maintain blood glucose at 100 mg/dl.

At week 26, both Byetta and Lantus reduced A1C levels by an average of 1.11%.

“[Byetta] reduced postprandial glucose excursions more than [Lantus],” write the researchers, “while [Lantus] reduced fasting glucose concentrations more than [Byetta].”

The researchers add that body weight decreased 5 pounds with Byetta and increased 4 pounds with Lantus.

Rates of hypoglycemia were similar, but nocturnal hypoglycemia occurred less frequently with the Byetta group. Gastrointestinal symptoms were more common in the Byetta group than in the Lantus group, including nausea (57.1 percent vs. 8.6 percent), vomiting (17.4 percent vs. 3.7% percent) and diarrhea (8.5 percent vs. 3.0 percent).

Annals of Internal Medicine, October 18, 2005

Click Here To View Or Post Comments

Categories: A1c Test, Blood Glucose, Byetta, Diabetes, Diabetes, Insulin, Lantus, Low Blood Sugar, Type 2 Issues, Type 2 Medications

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12th Annual Product Reference Guide
  • Insulin Syringe Chart
  • Insulin Pen Needles Chart
  • Fast-Acting Glucose
  • Sharps Disposal
  • Blood Glucose Meters Chart
  • Insulin Pumps Chart
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2015 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.